Drugs@FDA: FDA-Approved Drugs
Company: WYETH PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TRECATOR | ETHIONAMIDE | 250MG | TABLET;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/30/1965 | ORIG-1 | Approval | Type 1 - New Molecular Entity | PRIORITY |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/03/2023 | SUPPL-32 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013026s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/013026Orig1s032ltr.pdf | |
08/22/2016 | SUPPL-29 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013026s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/013026Orig1s029ltr.pdf |
04/29/2014 | SUPPL-28 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/14/2006 | SUPPL-24 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013026s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/013026s024LTR.pdf | |
11/08/2004 | SUPPL-23 | Manufacturing (CMC)-Formulation |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/13026s022,023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/13026s022,023ltr.pdf | |
11/08/2004 | SUPPL-22 | Manufacturing (CMC) |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/13026s022,023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/13026s022,023ltr.pdf | |
10/03/2001 | SUPPL-21 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
07/31/2001 | SUPPL-20 | Manufacturing (CMC)-Expiration Date |
Label is not available on this site. |
||
11/12/1998 | SUPPL-19 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
||
10/05/1998 | SUPPL-18 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/23/1998 | SUPPL-17 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/17/1994 | SUPPL-16 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
03/18/1994 | SUPPL-15 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
12/29/1992 | SUPPL-13 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/26/1991 | SUPPL-12 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/11/1990 | SUPPL-11 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
||
06/21/1989 | SUPPL-10 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
03/10/1997 | SUPPL-9 | Labeling |
Label is not available on this site. |
||
05/31/1988 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/04/1987 | SUPPL-7 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
03/03/1987 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
10/26/1984 | SUPPL-5 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
||
04/01/1981 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
06/20/1974 | SUPPL-3 |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/03/2023 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013026s032lbl.pdf | |
08/22/2016 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013026s029lbl.pdf |
06/14/2006 | SUPPL-24 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013026s024lbl.pdf | |
11/08/2004 | SUPPL-23 | Manufacturing (CMC)-Formulation | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/13026s022,023lbl.pdf | |
11/08/2004 | SUPPL-22 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/13026s022,023lbl.pdf |